Literature DB >> 6169993

Intrathecal use of interferon in encephalitis.

H Prange, H Wismann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6169993     DOI： 10.1056/NEJM198111193052113

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies.

Authors:  E A Obbens; L G Feun; M E Leavens; N Savaraj; D J Stewart; J U Gutterman
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

2.  Mechanisms of fever induced by recombinant human interferon.

Authors:  C A Dinarello; H A Bernheim; G W Duff; H V Le; T L Nagabhushan; N C Hamilton; F Coceani
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

3.  Early diagnosis and successful treatment of acute cytomegalovirus encephalitis in a renal transplant recipient.

Authors:  S Bamborschke; T Wullen; M Huber; M Neveling; C A Baldamus; K Korn; G Jahn
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

4.  Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis.

Authors:  L Jacobs; A M Salazar; R Herndon; P A Reese; A Freeman; R Josefowicz; A Cuetter; F Husain; W A Smith; R Ekes
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.